Search results

Articles (4)

Journals (0)

1-4 of 4 results for fotemustine

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published 2026

Fotemustine-containing chemotherapy suggests lower toxicity with comparable efficacy versus high-dose methotrexate-based regimens: a retrospective cohort analysis

Xudong Zhang, Wanyue Zhao, Wenhua Wang [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published July, 2010

Long-term Survival of Metastatic Melanoma to the Ileum with Evidence of Primary Cutaneous Disease after 15 years of follow-up: A Case Report

Venerina Sciacca, A Alida Ciorra, Concetta Di Fonzo [...]

Tumori Journal

Restricted accessResearch articleFirst published August, 2019

Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme

Francesco Buemi, Giuseppe Guzzardi, Bruno Del Sette [...]

The Neuroradiology Journal

Open accessAbstractFirst published February, 2015

Furthering benefit/risk ratio and cost effectiveness of anticancer drugs

A.S. Golikov, A.V. Tikhomirova

International Journal of Risk & Safety in Medicine

Search results

Articles (4)

Journals (0)

1-4 of 4 results for fotemustine

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published 2026

Fotemustine-containing chemotherapy suggests lower toxicity with comparable efficacy versus high-dose methotrexate-based regimens: a retrospective cohort analysis

Xudong Zhang, Wanyue Zhao, Wenhua Wang [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published July, 2010

Long-term Survival of Metastatic Melanoma to the Ileum with Evidence of Primary Cutaneous Disease after 15 years of follow-up: A Case Report

Venerina Sciacca, A Alida Ciorra, Concetta Di Fonzo [...]

Tumori Journal

Restricted accessResearch articleFirst published August, 2019

Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme

Francesco Buemi, Giuseppe Guzzardi, Bruno Del Sette [...]

The Neuroradiology Journal

Open accessAbstractFirst published February, 2015

Furthering benefit/risk ratio and cost effectiveness of anticancer drugs

A.S. Golikov, A.V. Tikhomirova

International Journal of Risk & Safety in Medicine